Join the Multiple Myeloma group to help and get support from people like you.
Multiple Myeloma News (Page 4)
Related terms: Cancer, Malignant Plasmacytoma, Cancer, Multiple Myeloma, Cancer, Plasma Cell Dyscrasia, Cancer, Plasma Cell Myeloma, Malignant Plasmacytoma, Myeloma, Multiple, Plasma Cell Dyscrasia, Plasma Cell Myeloma, Plasmacytoma of Bone, Kahler's disease
FDA Medwatch Alert: BiCNU (carmustine for injection): FDA Alert - Counterfeit Product Discovered in Some Foreign Countries
ISSUE: FDA is informing health care professionals that a counterfeit version of the FDA approved cancer drug, BiCNU (carmustine for injection) 100 mg, has been detected in some foreign countries....
FDA Grants Spectrum Pharmaceuticals Approval of Evomela (melphalan) for Injection
HENDERSON, Nev., March 15, 2016 --(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary...
FDA Approves Kyprolis (carfilzomib) Combination Therapy for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
THOUSAND OAKS, Calif., Jan. 21, 2016 /PRNewswire/ – Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) of...
FDA Approves Empliciti (elotuzumab) for Multiple Myeloma
November 30, 2015 – Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have...
FDA Approves Ninlaro (ixazomib) for Multiple Myeloma
November 20, 2015 – Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have...
FDA Approves Darzalex (daratumumab) for Patients with Previously Treated Multiple Myeloma
November 16, 2015 – Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior...
FDA Approves Farydak (panobinostat) for Multiple Myeloma
February 23, 2015 – The U.S. Food and Drug Administration today approved Farydak (panobinostat) for the treatment of patients with multiple myeloma. Multiple myeloma is a form of blood cancer that...
FDA Expands Indication for Revlimid (lenalidomide) in Combination with Dexamethasone to Include Patients Newly Diagnosed with Multiple Myeloma
SUMMIT, N.J., February 18, 2015 --(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has expanded the existing indication for...
FDA Approves Pomalyst for Advanced Multiple Myeloma
February 8, 2013 – The U.S. Food and Drug Administration today approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer...
FDA Approves Kyprolis (carfilzomib) for Patients with Advanced Multiple Myeloma
July 20, 2012 – The U.S. Food and Drug Administration today approved Kyprolis (carfilzomib) to treat patients with multiple myeloma who have received at least two prior therapies, including...
FDA Medwatch Alert: Revlimid (lenalidomide): Ongoing Safety Review - Increased Risk of Developing New Malignancies
[UPDATED 05/07/2012] FDA notified the public of an increased risk of second primary malignancies (new types of cancer) in patients with newly-diagnosed multiple myeloma who received Revlimid (...
Ask a question
To post your own question to this support group, sign in or create an account.